The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback